柯 文謙

Medicine & Life Sciences

1. Acinetobacter baumannii 13%
2. Aeromonas 20%
3. Anti-Bacterial Agents 12%
4. Anti-Infective Agents 6%
5. Bacteremia 44%
6. carbapenemase 5%
7. Carbapenems 26%
8. Cefepime 7%
9. Cefotaxime 9%
10. Cephalosporins 8%
11. Ciprofloxacin 6%
12. Clostridium difficile 11%
13. Clostridium Infections 8%
14. Colistin 6%
15. Coronavirus 12%
16. Dengue 5%
17. Enterobacter cloacae 5%
18. Enterobacteriaceae 12%
19. Escherichia coli 17%
20. Fever 6%
21. Fluoroquinolones 7%
22. Genes 7%
23. HIV 18%
24. Hospital Emergency Service 7%
25. Imipenem 10%
26. In Vitro Techniques 10%
27. Infections 21%
28. Intensive Care Units 9%
29. Intraabdominal Infections 6%
30. Meropenem 7%
31. Methicillin-Resistant Staphylococcus aureus 8%
32. Microbial Sensitivity Tests 9%
33. Minocycline 6%
34. Mortality 10%
35. Multicenter Studies 7%
36. Odds Ratio 9%
37. Pandemics 6%
38. Pneumonia 8%
39. Pseudomonas aeruginosa 7%
40. Q Fever 6%
41. Salmonella 9%
42. Severe Acute Respiratory Syndrome 6%
43. Therapeutics 8%
44. Tigecycline 13%
45. Vancomycin 5%